chenodeoxycholate sulfate conjugate: ester not salt of chenodeoxycholic acid; major product of enzymatic sulfation of chenodeoxycholic acid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 3081485 |
| MeSH ID | M0089610 |
| Synonym |
|---|
| 39280-88-1 |
| chenodeoxycholate sulfate conjugate |
| chenodeoxycholate 3-sulphate |
| cholan-24-oic acid, 3,7-dihydroxy-, hydrogen sulfate, (3alpha,5beta,7alpha)- |
| chenodeoxycholic acid sulfate conjugate |
| cdcs |
| (4r)-4-[(3r,5s,7r,8r,9s,10s,13r,14s,17r)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoic acid;sulfuric acid |
| 3,7-dihydroxycholan-24-oic acid--sulfuric acid (1/1) |
| DTXSID90960023 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.97) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (9.09%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (90.91%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||